SCHEMBL18976206

SCHEMBL18976206

Cn1cc(NC(=O)OC(C)(C)C)cc1C(=O)Nc1ccc2oc(C(=O)N3CCOCC3)cc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 5/20 0.46
▸ PRKDC P78527 1/20 0.45
▸ HRH4 Q9H3N8 2/20 0.41
▸ HRAS P01112 4/20 0.41
▸ ESR1 P03372 4/20 0.41
▸ ESR2 Q92731 4/20 0.41
▸ CD274 Q9NZQ7 1/20 0.41
▸ NPC1 O15118 4/20 0.40
▸ LMNA P02545 3/20 0.40
▸ MAPK1 P28482 2/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ TP53 P04637 3/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ THRB P10828 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18976462 0.92 NPC1 (0.45) RAB9APRKDCHRH4HRASESR1
SCHEMBL18976466 0.91 HRAS (0.41) RAB9APRKDCHRH4HRASESR1
SCHEMBL20580879 0.88 RAB9A (0.51) RAB9AHRH4HRASESR1ESR2
SCHEMBL18954276 0.86 HRAS (0.40) PRKDCHRH4HRASESR1ESR2
SCHEMBL18976174 0.86 HRAS (0.39) PRKDCHRH4HRASESR1ESR2
SCHEMBL18976175 0.85 HRAS (0.45) RAB9APRKDCHRASESR1ESR2
SCHEMBL18976017 0.84 PRKDC (0.47) PRKDCCD274MEN1KMT2ATP53
SCHEMBL18976463 0.83 HRAS (0.45) RAB9APRKDCHRASESR1ESR2
SCHEMBL18976117 0.82 GAA (0.45) PRKDCHRH4CD274KMT2ATHRB
SCHEMBL18976322 0.82 HRAS (0.46) RAB9APRKDCHRASESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10640507-B2 PBD antibacterial agents KING'S COLLEGE LONDON (GB) 2020-05-05 — — US disclosed
WO-2017098257-A1 PBD ANTIBACTERIAL AGENTS KING'S COLLEGE LONDON (GB) 2017-06-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10640507-B2 PBD antibacterial agents OPRD1, XDH, SBDS RAB9A 3045/4885PRKDC 4382/4885HRH4 13/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback